Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eledon Pharmaceuticals, Inc.

3.36
+0.0000
Post-market: 3.360.00000.00%16:05 EDT
Volume:131.75K
Turnover:438.07K
Market Cap:201.20M
PE:-4.51
High:3.41
Open:3.38
Low:3.27
Close:3.36
Loading ...

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
25 Mar

Guggenheim Remains a Buy on Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
24 Mar

BRIEF-Eledon Pharmaceuticals FY Operating Expenses USD 70.577 Million

Reuters
·
21 Mar

Eledon Pharma FY 2024 GAAP EPS $(0.75) Misses $(0.64) Estimate

Benzinga
·
21 Mar

Eledon Pharmaceuticals: Proceeds From Oversubscribed $85 Million Underwritten Offering Extend Cash Runway to End of 2026

THOMSON REUTERS
·
21 Mar

Eledon Pharmaceuticals: Topline Results From Phase 2 Bestow Trial of Tegoprubart in Kidney Transplantation Expected in Fourth Quarter of 2025

THOMSON REUTERS
·
21 Mar

Eledon Pharmaceuticals FY Basic EPS USD -0.75

THOMSON REUTERS
·
21 Mar

Press Release: Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

Dow Jones
·
21 Mar

Eledon announces tegoprubart use in transplant of pig kidney into human

TIPRANKS
·
07 Feb

Eledon initiated with a Buy at Guggenheim on tegoprubart opportunity

TIPRANKS
·
28 Jan

Guggenheim Initiates Eledon Pharmaceuticals at Buy With $9 Price Target

MT Newswires Live
·
28 Jan

Eledon Pharmaceuticals (ELDN) Receives a Rating Update from a Top Analyst

TIPRANKS
·
15 Jan

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

THOMSON REUTERS
·
13 Jan

Eledon Pharmaceuticals: on Track to Report Topline Results in Q4 of 2025

THOMSON REUTERS
·
13 Jan

Eledon Pharmaceuticals Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
20 Nov 2024

Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions

Simply Wall St.
·
14 Nov 2024

Eledon Pharmaceuticals price target lowered to $20.50 from $28 at Ladenburg

TIPRANKS
·
13 Nov 2024

Eledon Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Eledon Pharma Q3 EPS $(0.32) Misses $(0.30) Estimate

Benzinga
·
13 Nov 2024

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

THOMSON REUTERS
·
13 Nov 2024